Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Aeres Medical to Present at Medtech Insight's ``Investment In Innovation'' Conference.


SAN FRANCISCO San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden  -- Aeres Medical has announced that it will be presenting at 10:30 am on Wednesday, June 15 at Medtech Insight's Prestigious "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" Conference, taking place June 14-15, 2005 at The Palace Hotel in San Francisco, CA.

Obesity is reaching epidemic proportions with more than 300 million Americans and Europeans overweight. Out of this group, more than 100 million are clinically obese. This increasing trend is driving a multi-billion dollar weight loss industry and causing an additional burden on the healthcare industry. Current medical treatments for this disease are limited to prescription pharmaceuticals and surgery. Because of their unwanted side effects Side effects

Effects of a proposed project on other parts of the firm.
, existing weight loss medications are not often prescribed. Surgical procedures Surgical procedures have long and possibly daunting names. The meaning of many surgical procedure names can often be understood if the name is broken into parts. For example in splenectomy, "ectomy" is a suffix meaning the removal of a part of the body. "Splene-" means spleen.  are very expensive, and are only recommended in the direst circumstances. Clearly there is a need for a non-invasive, non-pharmacologic solution for weight loss and prevention of obesity in overweight patients.

Aeres Medical has developed a noninvasive medical device providing low-risk hypoxic hypoxic

a state of hypoxia.


hypoxic cell sensitizers
compounds that selectively sensitize hypoxic tumor cells to the effects of radiation.
 treatment that induces appetite suppression and weight loss. Aeres(TM) Medical's ThinAir(TM) system provides a unique treatment for obesity without invasive surgery Invasive surgery
A form of surgery that involves making an incision in the patient's body and inserting instruments or other medical devices into it.

Mentioned in: Laser Surgery
 or pharmacological treatments. The ThinAir(TM) system is based on the existing patented technology of Aeres Medical's parent company, Colorado Altitude Training Altitude training traditionally called training at an altitude camp, or now commonly using altitude simulation tents or mask based hypoxicator systems is the practice by some endurance athletes of training at high altitude, usually over 2,500 m (8,000 ft) above sea level, . The Company's proprietary technology, based on medical hypoxia hypoxia

Condition in which tissues are starved of oxygen. The extreme is anoxia (absence of oxygen). There are four types: hypoxemic, from low blood oxygen content (e.g., in altitude sickness); anemic, from low blood oxygen-carrying capacity (e.g.
, reduces the amount of inspired oxygen and induces physiological changes equivalent to those seen at high altitude, including a weight loss of one to two pounds per week. Hypoxia-associated weight loss has been studied for decades, and has been specifically addressed in detail in numerous scientific publications and studies. Although this is a well-known phenomenon, until the Aeres ThinAir(TM) system, there has been no practical method for bringing hypoxia into the clinical setting for therapeutic applications.

The system is comprised of a clear tent which fits securely over the sleeping area (models will fit most standard bed sizes); an innovative oxygen control system which monitors oxygen concentration and allows altitude adjustment based on the company's proprietary altitude conversion software; and an air unit based on well established air separation technology that produces a quiet, high flow of hypoxic air simulating altitudes up to 14,000 feet. Patients sleep in the ThinAir(TM) System tent and go about the rest of their day normally, without having to restrict their diet or increase their exercise.

Aeres management is currently comprised of CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Larry Kutt, VP Dede Willis and VP Bob Beckemeyer. This management team has over 65 years of combined experience in startups, life sciences, and operations.

Medtech Insight, a division of Windhover wind·hov·er  
n. Chiefly British
A kestrel.
 Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. To register for the "Investment In Innovation" conference or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512, e-mail kristy@medtechinsight.com, or visit www.medtechinsight.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 9, 2005
Words:476
Previous Article:BAE SYSTEMS-Raytheon Team to Provide Next Generation Mission Planning Capabilities for The U-2.
Next Article:Aperio Technologies to Present at Medtech Insight's ``Investment In Innovation'' Conference; Aperio CEO Presents Value Proposition and Growth...



Related Articles
European Medical Device Start-Up Industry is Poised for Tremendous Growth, According to Medtech Insight and Windhover Information.
50 Early-Stage Medical Technology Companies to be Showcased at Medtech Insight's 'Investment In Innovation' Conference, June 14-15, 2005, San...
'Creating Companies That Work' Will Be the Topic of Discussion of a Panel of Medical Device Entrepreneurs at Medtech Insight's 'Investment In...
50 Emerging Medical Technology Companies to be Showcased at Medtech Insight's In3 EUROPE Investment and Partnering Conference in Brussels, Belgium;...
Medtech Insight's In3 EUROPE Investment and Partnering Conference in Brussels, Belgium, to Feature Panel Discussion Focusing on European Venture...
Early-Stage Cardiovascular, Spine/Orthopedic, Oncology, Drug Delivery, Biomaterials and Imaging Companies from around the World Are among the 50...
Over 30 Early-Stage Medical Technology Start-Ups from Around the World Are Confirmed to Present at Medtech Insight's In3 EUROPE Investment and...
Nearly 40 Early-Stage Medical Technology Companies from around the World Are Confirmed to Present at Medtech Insight's In3 EUROPE Investment and...
Only Two Weeks to Go until Medtech Insight's In3 EUROPE Start-Up Medical Technology Investment and Partnering Conference, Sept. 20-21.
FINAL ANNOUNCEMENT for Medtech Insight's 'Investment In Innovation (In3) EUROPE' Start-Up Medical Technology Investment and Partnering Conference,...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles